Navigation Links
High zinc status in lung cells slows growth and induces DNA damage-induced gene expression
Date:2/25/2008

Researchers at the University of Maryland at College Park have discovered that Normal Human Bronchial Epithelial (NHBE) cells cultured in medium with elevated zinc level, at the high end of plasma zinc attainable by oral supplementation, demonstrated inhibition of cell growth, up-regulation of growth arrest and DNA damage-induced gene (Gadd45) mRNA and protein expression, and blockage of G2/M cell cycle progression. The research, published in the March 08 issue of the Experimental Biology and Medicine, demonstrated that the essential nutrient zinc, at elevated physiologic level, is capable of inducing stress responsive genes in the NHBE cells. NHBE cells function as a protective airway barrier and are representative of the cell population during lung tissue transformation and are considered to be progenitor cells for human bronchial cancer.

Gadd45 is ubiquitously expressed in response to genotoxic agents, and is involved in many biological processes related to the maintenance of genomic stability and apoptosis. Over expression of Gadd45 was found to induce G2/M cell cycle arrest. The importance of Gadd45 in G2/M regulation was further supported by findings of the inability of cells from Gadd45 knockout mice to arrest at the G2/M phase after exposure to UV radiation. In addition, a functional association between stress-activated mitogen-activated protein kinase p38 pathway and Gadd45 in response to environmental stresses has been established in past studies. Moreover, the dependence of Gadd45 induction for the normal function of the tumor suppressor gene p53, which plays an important role in the maintenance of genomic fidelity by controlling cell cycle checkpoints and apoptotic processes following cell exposure to genotoxic stress, is well established. Furthermore, in response to DNA damage, Gadd45 was found to contribute to the stability of p53.

The research team, led by David K. Y. Lei, a professor of Nutrition, and Rita S. M. Shih, a recent doctoral graduate, designed the study to determine the influence of zinc status on Gadd45 expression and cell cycle progression in NHBE cells, and to decipher the molecular mechanism(s) exerted by the suppression of Gadd45 expression on cell growth and cell cycle progression in this normal human cell type.

Inhibition of cell growth, up-regulation of Gadd45 mRNA and protein expression, and blockage of G2/M cell cycle progression were observed in NHBE cells cultured in high zinc medium - the zinc supplemented (ZS) cells said Lei. The siRNA-mediated knocking down of Gadd45 was found to relieve G2/M blockage in ZS cells, which indicated that the blockage was Gadd45 dependent. Moreover, the enhanced phosphorylation of p38 and p53 (ser15) observed in ZS cells was normalized after suppression of Gadd45 by siRNA, implicating that the enhanced phosphorylation of these proteins was Gadd45 dependent. Thus, the researchers demonstrated for the first time that an elevated zinc status modulated the p53 and p38 signal transduction pathways to produce a delay at G2/M during cell cycle progression in NHBE cells.

Lei says the use of normal human cell types to evaluate the influence of nutrients and bioactive plant materials on the expression of stress responsive genes and cell cycle progression is a rapid and valuable approach to identify potential targets and provide mechanistic data. However, the applicability of these in vitro mechanistic data would require confirmation by detailed in vivo studies

Dr. Steven R. Goodman, Editor-in-Chief of Experimental Biology and Medicine said This study on the molecular and cellular response of NHBE cells to a high zinc challenge may have important implications for conditions such as industrial exposure and extensive usage of zinc supplementation in animal production and in humans. He further stated The use of molecular and cellular approaches to address problems in nutritional sciences is the type of interdisciplinary study that the new Experimental Biology and Medicine is interested in publishing.


'/>"/>

Contact: David K.Y. Lei
dlei@mail.umd.edu
301-405-2143
Society for Experimental Biology and Medicine
Source:Eurekalert

Related medicine news :

1. TransUnion Addresses Ohio Attorney Generals Concerns Surrounding Non-Profit Tax-Exempt Status
2. Timely Cancer Diagnosis Linked to Insurance Status
3. Major study links insurance status to advanced stage in multiple cancers
4. Landmark Articles Published by QualityMetric Scientists Report Improvements in Short Form Health Status Measures and Establish Criteria for Future Development
5. Ocera Therapeutics Receives Orphan Drug Status for AST-120 for Pouchitis
6. Insurance status linked to cancer outcomes
7. Alzheimers Foundation of America Awards Excellence in Dementia Care Status to First Adult Day Center, More Long-Term Care Settings
8. Isis Announces ISIS 333611 Granted Orphan Drug Status for Treatment of ALS
9. TREANDA New Drug Application for the Treatment of Chronic Lymphocytic Leukemia Granted Priority Review Status by FDA
10. Unstable housing status increases the risk of HIV transmission
11. Global view shows link between endometrial cancer and vitamin D status
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... LaserShip, a regional parcel carrier that services the ... Eastern Michigan last Friday in order to aid in the Flint water crisis. In ... a facility located in Clio, only 15 miles away from Flint. , “We have ...
(Date:2/10/2016)... ... February 10, 2016 , ... InDemand ... within Healthcare, recently partnered with Heart City Health Center to improve ... 23 years, Heart City Health Center has provided the Elkhart community with access ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... 10 ... Brand. There were three leading bottled water brand owners that topped the list as ... enhance connectivity and optimize conversion. The premier brand was Tibet 5100, a top notch ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... welcomes S.S. Nesbitt as the latest addition to its growing list of Partner ... locations throughout the Southeast, from Orlando to Huntsville and in between. , Harnessing ...
(Date:2/10/2016)... ... February 10, 2016 , ... Pediatric therapists are challenged to ... shows that the Goal Attainment Scale (GAS) captures 20% more change in outcomes ... more about the Goal Attainment Scale, Education Resources Inc. is offering a course ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... and PITTSBURGH, Feb. 10, 2016 Mylan N.V. (NASDAQ, ... quarter and year ended December 31, 2015. ... Full year adjusted total revenues of $9.45 billion, up ... year; GAAP total revenues of $9.43 billion. Excluding the ... markets specialty and branded generics business (the "EPD Business"), ...
(Date:2/10/2016)... , Feb. 10, 2016  Resolve Therapeutics, ... transformative new approaches to the treatment of lupus ... of a multiple ascending dose study in patients ... compound RSLV-132. --> ... placebo-controlled multiple ascending dose study of RSLV-132 in ...
(Date:2/10/2016)... , Feb. 10, 2016  Rich Pharmaceuticals, Inc. (OTC ... a 1-for-100 reverse split of its issued and outstanding ... trading on Thursday, February 11, 2016. The Company,s common ... CUSIP number 76303T308 and temporary ticker symbol "RCHAD". After ... under the ticker symbol (RCHA).  --> ...
Breaking Medicine Technology: